+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Alli"

Anti-Obesity Drugs Market Report and Forecast 2025-2034 - Product Thumbnail Image

Anti-Obesity Drugs Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Anti-Obesity Drug Market - Forecast from 2026 to 2031 - Product Thumbnail Image

Anti-Obesity Drug Market - Forecast from 2026 to 2031

  • Report
  • January 2026
  • 146 Pages
  • Global
From
Anti-obesity Medication Market - Product Thumbnail Image

Anti-obesity Medication Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Anti-obesity Drug Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Anti-obesity Drug Market Forecasts from 2023 to 2028

  • Report
  • October 2023
  • 140 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

The Alli market is a segment of the anti-obesity drug industry. Alli is a weight loss aid that is available over-the-counter and is the only FDA-approved over-the-counter weight loss drug. Alli works by blocking the absorption of some of the fat from the food that is eaten. It is intended to be used in conjunction with a reduced-calorie, low-fat diet and regular exercise. Alli is marketed as a weight loss aid that can help people lose more weight than diet and exercise alone. The Alli market is highly competitive, with many companies offering similar products. Some of the major players in the Alli market include GlaxoSmithKline, Novo Nordisk, Merck, and Pfizer. Other companies in the market include Allergan, Sanofi, and Johnson & Johnson. Show Less Read more